By Sriparna Roy (Reuters) -Akero Therapeutics shares gained 106% before the bell on Monday, after its lead drug showed it can ...

Dr Amir Khan has warned over a condition that affects one in five Brits - and can be caused by a range of factors with very ...

Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study ...

A dietary supplement used to build muscle – or prevent muscle loss as a result of ageing or illness – is to be trialled as a potential treatment for chronic liver disease.

Researchers find that allergy medicine could help patients with a rare genetic disease avoid liver transplants.

Chlorcyclizine shows promise in reducing protoporphyrin-IX accumulation and liver damage in erythropoietic protoporphyria, ...

Akero's SYMMETRY Phase 2b study showed 50mg EFX achieved 24% cirrhosis reversal in MASH patients, with improvements in liver ...

"Now, most people will have no symptoms, and the diagnosis is often picked up through a random blood test or a scan. But ...

Salk scientists have found that eliminating the bile acid-producing protein BAAT and supplementing with the bile acid UDCA ...

A Cleveland Clinic study reveals that bariatric surgery significantly reduces the risk of serious liver complications in ...

Rutgers Health researchers find that allergy medicine could help patients with a rare genetic disease avoid liver transplants ...